Market Research Blog – Page 14697 – New Product Development

Hand, Foot and Mouth Disease Treatment Market Size, Share, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2028

Hand, foot, and mouth disease commonly abbreviated as HFMD is a contagious disease caused by multiple enterovirus serotypes majorly Coxsackievirus A16 and enterovirus A71. These virus usually spread through faecal-oral transmission owing to improper hand wash. Enterovirus A71 has been associated with HFMD disease outbreaks that involved thousands of people in Asia region. HFMD is a clinical syndrome being one of the most detectable viral exanthemas in children below 5 years of age, which is usually characterized by oral anathema, Maculopapular, a macular, or vesicular rashes on the hands and feet. This viral disease causes rashes or blisters in the mouth and on the palms of hands and soles of feet. It also causes blisters in the mouth at the back of throat.

Usually children under the age of 10 are most likely to be at risk for hand-foot-and-mouth disease. Also, the incubation period for hand-foot-and-mouth disease usually is 3 to 7 days. A person starts developing symptoms of hand-foot-and-mouth disease 3-7 days after being exposed to the virus. Symptoms for hand-foot-and-mouth disease may vary from children to children. Some of the major symptoms include: blisters in mouth usually at the back of throat, small blisters in diaper area, on sole of feet and palm of hands, rashes on arms and legs, high fever, lack of appetite and others. It is mandated to get the children diagnosed if a child below age of 5 shows the above mentioned symptoms.

A physical examination is conducted to diagnose the rashes, which is unique to hand-foot-and-mouth disease. Along with the rash examination, throat culture or stool sample is also extracted for laboratory testing of HFMD. Hand, foot and mouth disease treatment drugs are capable of extreme performance and allow significant recovery, thus contribute majorly to the revenue generation in hand, foot and mouth disease treatment market. However, treatment for HFMD majorly depends on how severe the condition is, child’s symptoms, age, and overall health of a person. This illness is usually not treated with antibiotics or other commercial drugs at a large level as the goal of treatment is to reduce symptoms which can be done using home remedies. It is advised to drink cold fluids in order to soothe mouth pain. Drugs such as acetaminophen, paracetamol or ibuprofen are given to reduce fever and discomfort. Mouth rinse or sprays containing pain reliever are used to reduce mouth pain. However, drugs such as aspirin are not recommended for children as it may cause Reye syndrome.

The hand, foot and mouth disease treatment is broadly used to treat sore conditions in mouth, hand or feet of children caused by Coxsackievirus A16 or enterovirus A71, that experience greater demand, thus generating large revenues in the hand, foot and mouth disease treatment market. Hand, foot and mouth disease treatment market on the basis of drug type is classified into acetaminophen, paracetamol and ibuprofen. However, the main distribution channel for hand, foot and mouth disease treatment include hospital pharmacies, retail pharmacies, drug stores, e-commerce and others. On the other hand, Hand, foot and mouth disease treatment market is gaining profit due to rising incidence of chronic diseases in the children below age 10 across the globe. A large number of preventive vaccines to prevent children from HFMD are still under clinical trials. Some of the preventive measures to reduce the risk of getting infected with HFMD causing virus includes washing hands for 20 seconds after changing diaper, practice hygiene and cleanliness, avoid close contact with the infected person, disinfect frequently touched surfaces by infected person, and others. Hand, foot and mouth disease treatment consist of various over-the-counter pain relievers and fever reducer drugs and registers a significant revenue growth in the hand, foot and mouth disease treatment market. The growing incidence of children acquiring this viral infection causing HFMD is further anticipated to drive the revenue generation in hand, foot and mouth disease treatment market over the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6922

Hand, Foot and Mouth Disease Treatment: Market Dynamics

Growing awareness regarding hand, foot and mouth disease treatment among people, availability of cost effective drugs in the market, and high prevalence of viral infection causing HFMD in children across the globe is expected to be the key factor driving growth of hand, foot and mouth disease treatment market. The growing footprint of pharmaceutical manufacturers in the APAC region coupled with growing economic burden for hand, foot and mouth disease in Asia Pacific countries is expected to drive the demand for hand, foot and mouth disease treatment drugs, thereby generating more revenues in hand, foot and mouth disease treatment market. Also, developed healthcare infrastructure and rising awareness programs for HFMD and increasing funding for clinical trials on hand, foot and mouth disease treatment drugs are some other factors propelling the growth of hand, foot and mouth disease treatment market. Also, ease in FDA approvals for HFMD drugs in clinical trial phase is further expected to drive the growth of hand, foot and mouth disease treatment market. However, risk of acquiring other diseases such as Reye syndrome on consumption of pain relief drugs such as Aspirin is one of the major factor restraining the hand, foot and mouth disease treatment market growth.

Hand, Foot and Mouth Disease Treatment Market: Overview

Based on drug type, Acetaminophen registers the highest demand in the hand, foot and mouth disease treatment market owing to the less side effects registered with usage of this drug as compared to others. Hand, foot and mouth disease treatment found major usage in management of blisters in mouth and rashes on hands and feet. Rising prevalence of viral infections in children below age 10 and growing economic burden caused by HFMD is one of the major factor driving the demand of hand, foot and mouth disease treatment drugs for early management of viral infection in children, thereby fueling the hand, foot and mouth disease treatment market over the globe.

Hand, Foot and Mouth Disease Treatment Market: Region-wise Outlook

On the basis of geography, global hand, foot and mouth disease treatment market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. Asia Pacific is projected to hold largest shares in the global hand, foot and mouth disease treatment market primarily due to growing prevalence of HFMD in children in APAC region coupled with Asia Pacific being the most vulnerable area for a number of outbreaks of EV71 HFMD. North America followed by Western Europe registers the second largest revenue share in global hand, foot and mouth disease treatment market worldwide followed by Japan.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6922

Hand, Foot and Mouth Disease Treatment Market: Key Players

Some of the key players present in global hand, foot and mouth disease treatment market are Adimmune Corp., CJ HealthCare Corp., Takeda Pharmaceutical Co Ltd., Shanghai Zerun Biotechnology Co Ltd., Chongqing Zhifei Biological Products Co Ltd. and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Hand, Foot and Mouth Disease Treatment Market: Segmentation

The global hand, foot and mouth disease treatment market is segmented by drug type and distribution channel:

Segmentation by Drug Type

Acetaminophen (Tylenol)
Ibuprofen (Advil)
Paracetamol
Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6922

Segmentation by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-Commerce

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Automated Microbial Detection Systems Market Research Report: Key Drivers and Restraints, Opportunities, Industry Share & Trend Analysis Report to 2028

A number of infectious diseases and the increasing number of resistant strains of microorganisms lead to the development of microbial detection kits. However these traditional methods of culturing and then identification is time consuming. Automated microbial detection systems is one solution for this problem. Using these systems the detection process of microorganisms can be done within a few minutes of culturing and the results could be available within a couple of hours. Automated microbial detection systems are automated tools used for the detection of key contaminant microorganisms. These methods allow for preventive controls and faster testing. The results could be obtained within a few hours using the automated microbial detection systems, when compared to the traditional culturing methods.

A number of large and small players provide automated microbial detection systems. Some of them include Thermo Fisher Scientific, Lonza, Pall Corporation, MediRay, BioMeriux and MIDI Inc.

Market Dynamics of Automated Microbial Detection Systems Market

A number of factors drive the growth of the automated microbial detection systems market. Some of these include the increase in incidence of infectious diseases that are coupled with epidemic and pandemic events that occur every year. Increasing food safety concerns is another factor that drives the growth of the automated microbial detection system market. Technology advancements and government initiatives to aid the development of the market further. However, high cost of automated microbial detection systems and complex regulatory framework slightly hinder the growth of the automated microbial detection systems market.

Genotypic Methods are Popularizing

When genotypic methods are applied for the identification of microorganisms it results in specie-specific fingerprints. The genotypic methods of automated microbial detection systems are fast and reliable. New genotypic methods include the use of microchips coated with an array of oligonucleotides that allows rapid identification, by the determination of patterns or sequences that are specific to an organism. DNA sequencing and biochemical sequencing coupled with fluorescent analysis of the product is also being developed for automation.

Automated Microbial Detection Systems Market by Technology

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6955

Regional Market Outlook

Although North America will continue to hold the largest share in the automated microbial detection systems market, Asia-Pacific is expected to grow with the largest CAGR. The continued focus of the major player towards emerging and Asian countries as well as due to the support of the government in these region leads to development of the automated microbial detection systems market in the region.

Competition Outlook

Automated Microbial Detection Systems are expensive devices. Thus the Automated Microbial Detection System Market is dominated by large players like Thermo Fisher Scientific, Becton Dickinson, Merck Millipore and Lonza. The other small players include Biomerieux, MIDI Inc and MediRay.

Small-Scale Manufacturers/Providers	Medium-Scale Manufacturers/Providers	Large-Scale Manufacturers/Providers
MediRay Micro Identification Technologies MIDI, Inc.	Trivitron Healthcare Biomerieux	Thermo Fisher Scientific VWR (Avantor) Becton Dickinson Charles River Merck Millipore Lonza Pall Corporation

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.

Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6955

Key data points covered in report

The report covers exhaustive analysis on:

Automated Microbial Detection Systems Market by technology, end user and region
Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by technology, end use segments and country
Automated Microbial Detection Systems Market Dynamics & Opportunity Assessment
Historical Actual Market Size, 2013 – 2017
Automated Microbial Detection Systems Market Size & Forecast 2018-2028
Automated Microbial Detection Systems Market Trends/Issues/Challenges
Competition & Companies involved

Market Segmentation

By Technology

Phenotypic Methods
Genotypic Methods

By End user

Pharmaceutical and Biotechnology Industry
Food & Beverages Industries
Water & Environment Industries
Diagnostic Laboratories
Blood Banks
Hospitals
Others

By Region

North America
Western Europe
Eastern Europe
Latin America
Asia Pacific
Japan
Middle East & Africa

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/6955

Report Highlights:

Shifting industry dynamics
In-depth market segmentation
Historical, current and projected industry size, recent industry trends
Key competition landscape, market structure, regulatory scenario
Economical spending, regional healthcare outlook, consumer healthcare expenditure
Strategies for key players and product offerings, channel strategies, regional foot print, channel footprint
A neutral perspective towards market performance in terms of value

Asthma and COPD Biomarkers Market Key Players, Products Type, Application Types and Production Information Analysis and Forecast 2028

Chronic Obstructive Pulmonary Disease (COPD) are a group of progressive lung diseases which interfere with the airflow and make it difficult to breathe. The lung disease include non-reversible asthma, emphysema chronic bronchitis. The air flow is narrowed due to the damage of the lung tissues. Air pollution and smoking are the main risk factors of this disease. COPD is a common and incurable disease which is characterized by increased breathlessness, persistent respiratory symptoms and airflow limitations. The biomarkers are obtained in the form of bronchi alveolar fluids sputum, blood, urine and exhaled breath. These compounds are produced by the metabolic process in the body and are non-invasive metabolic markers. These biomarkers provide information to verify the disease, its stage, treatment and responses.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/asthma-and-copd-biomarkers-market

Factor driving the Asthma and COPD Biomarker market

Asthma and COPD biomarker market is primarily driven by the increasing smoking rate and growing pollution levels. According to WHO reports 64 million people had COPD and 3 million people died of COPD in 2004. Long-term exposure to chemical fumes, vapours and dusts are also some factors which are causing COPD and driving the market. Moreover the demand of breath analyzers is increasing in schools hospitals and other institutions to ensure the safety of the individuals.

The COPD biomarkers are non-invasive and are produced by the metabolic process in the body in the form of urine, sputum, and by exhaled breath etc. Increased levels of FeNO (Fractional exhaled nitric oxide) in exhaled breath is obtained by the hand held breath analyzers. These devices are easy to use and quick in diagnoses of the disease. Fibrinogen as a biomarker is measured in the plasma. Its increased levels provide the severity of COPD, airflow colonization and emphysema. The increased level of fibrinogen, white blood cells and C- reactive protein (CRP) combined together is accounted as a major risk for COPD. However, lack of awareness and diagnosis of chronic obstructive pulmonary diseases is hindering the growth of asthma and COPD biomarker market. Also if the disease is not detected at the earliest stage it could lead to respiratory infections, heart problems, lung cancer and high blood pressure. The overall market of asthma and COPD biomarker is pushed by the increasing demand of growing expenditure on healthcare. Asthma and COPD biomarker market offers the potential to identify disease in its earliest phase and the technology in the devices and the test kits holds a strong perception in future with its continued investment.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6937

Competition Outlook

Some of the major players identified in Asthma and COPD biomarker market are Spirosure inc. GE Healthcare, Astrazeneca, Owlstone Medical Ltd, Circassia Limited, Bedfont® Scientific Ltd., ECO MEDICS AG., Vitalograph, Mologic ltd, Akers Biosciences, Inc etc. The Companies are involved in collaboration agreements for R&D in order to exploit maximum potential. Also they are mainly focused to strengthen the core competencies of their product portfolio with the increasing demand for the diagnosis of COPD and asthma.

Small Scale Manufacturers/Providers	Medium Scale Manufacturers/Providers	Large Scale Manufacturers/Providers
Mologic ltd, Akers Biosciences, Inc	Circassia Limited Bedfont® Scientific Ltd Vitalograph ECO MEDICS AG. Spirosure inc.	GE Healthcare Astrazeneca Owlstone Medical Ltd

Research Methodology

The market sizing of Asthma and COPD biomarker market will be done by adoption data triangulation approach. Demand side approach will be followed to assess the actual market size of Asthma and COPD biomarker. Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of test and among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analyzed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side respondents such as physicians, laboratory and diagnostic laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6937

Key data points covered in report

The report covers exhaustive analysis on:

Asthma and COPD biomarker market by target areas, modality, end user and region
Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by method type, end user and country segments
Asthma and COPD biomarker Market Dynamics & Opportunity Assessment
Historical Actual Market Size, 2013 – 2017
Asthma and COPD biomarker market Size & Forecast 2018-2028
Asthma and COPD biomarker Current Trends/Issues/Challenges
Competition & Companies involved

Market Segmentation

Market by application

Chronic Bronchitis
Emphysema
Refractory Asthma

Market by Test Type

Breath Analyzing
Sputum tests
Urine tests
Plasma tests

Market by End user

Hospitals
Diagnostic Laboratories
Asthma Clinics

Market by Region

North America
Latin America
Europe
Asia Pacific Excluding Japan
Japan
Middle East & Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6937

Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape, market structure, regulatory scenario
Epidemiology outlook for diseases
Economical spending, regional healthcare outlook, consumer healthcare expenditure
Availability of device, cost of the test, specificity and sensitivity
Strategies for key players and product offerings, Channel strategies, regional foot print, channel footprint
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance in terms of value and volume

Pressure Infusion Bags Market is expected to increase at a CAGR of ~6.5% during the forecast period of 2022-2029

[317 Pages Report] A new market research report by Future Market Insights on the pressure infusion bags market includes global industry analysis 2014 – 2021 and opportunity assessment 2022 – 2029. The report investigates the pressure infusion bags market and provides critical insights for the forecast period of 2022 -2029.

As per the findings of the report, the global pressure infusion bags market is projected to experience significant growth over the forecast period due to multiple driving factors such as increasing emergency and transfusion cases and development of healthcare infrastructure across geographies.

The global pressure infusion bags market was valued at ~US$ 300 Mn in 2021, and is expected to increase at a CAGR of ~6.5% during the forecast period of 2022-2029. This growth is majorly driven by the increasing use of pressure infusion bags for rapid infusion of blood and drugs, in order to protect the end organ damage during traumatic conditions.

The overall progress of the healthcare sector and infrastructure in MEA and Asia-Pacific are likely to unfold lucrative opportunities for market players operating in the pressure infusion bags market. In addition, manufacturers are expected to primarily focus on developing cost-effective and user-friendly bags in the coming years.

South Asia Continues to Hold Lucrative Opportunities

Regions such as North America and East Asia are expected to hold prominent market shares in terms of value. However, the South Asia market is expected to project lucrative growth in the global pressure infusion bags market over the forecast period of 2022-2029.

This growth is propelled by the rapid growth and development of healthcare infrastructure, especially trauma care units, intensive care units and ambulatory surgical centers in countries of South Asia that include India and ASEAN countries. The economic condition of these countries have been developing positively, thereby creating newer growth opportunities for the market players.

Macroeconomic factors such as growing population, increasing immunosuppressed patient population, and increase in the number of players along with strong distribution network and rapid development in the healthcare infrastructure have attracted the attention of manufactures to establish a firm collaboration with local distributors in South Asia.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2243

Hospitals and Outpatient Facilities Remain Key End Users for Pressure Infusion Bags

The global market of pressure infusion bags has been segmented on the basis of different types of pressure infusion bags products, their multiple applications, their volume capacity, their material, their targeted indications and regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East and Africa.

By type, the disposable type of pressure infusion bags segment is expected to hold prominent value shares of the global pressure infusion bags market. This has majorly resulted to avoid and minimizing chances of cross contamination during fluid infusion and ensures the patient safety
On the basis of application, the blood and drug infusion segment is expected to consume majority share of the global pressure infusion bags market value. Invasive Pressure monitoring procedures is the second application which account the remaining market share.

Pressure Infusion Bags Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global pressure infusion bags market. Some of the examples of key players in the global pressure infusion bags market are VBM Medizintechnik GmbH, ERKA, Smiths Medical (Smiths Group plc.), Friedrich Bosch GmbH & Co. KG, Biegler GmbH, SARSTEDT AG & Co. KG. Vyaire Medical Inc., Spengler SAS, Armstrong Medical, SunMed and Statcorp Medical

Pressure Infusion Bags Market by Category

By Product:

Reusable Pressure Infusion Bags
Disposable Pressure Infusion Bags

By Material:

Nylon
Polyurethane
Latex
Others

By Capacity:

500cc
1000cc
3000cc
Above 3000cc

By Application:

Blood & Drug Infusion
Invasive Pressure Monitoring Procedure

By Indications:

Trauma-Induced Haemorrhage
Obstetric Haemorrhage
Coagulopathy during cardiopulmonary bypass

By End User:

Hospitals
Out-patient facilities
Clinics
Long-term care centers

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2243

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Vacuum Mixing Devices Market value of around US$ 157.9 Million as of 2022

[199 Pages Report] Driven by the demand for efficient medical laboratory equipment and the changing face of healthcare models, the global market for vacuum mixing devices – valued at ~ US$ 154.0 Mn in 2021 – is estimated to grow by ~ 2% YOY in 2022. These insights are according to a new research report by Future Market Insights (FMI), which underlines the key headwinds and tailwinds determining the future potential of vacuum mixing devices market.

The FMI analyst is of the opinion that market gains will further be upheld by the clinical benefits associated with use of vacuum mixing devices. FMI expects the vacuum mixing devices to see unwavering growth in the next 10 years, as the global healthcare space actively embraces ‘efficiency-enabling’ medical mixing equipment.

Medical mixing processes have remained challenging for a long period of time, primarily undermined by the lack of competent technologies. With gradual evolution of vacuum mixing devices, a wide range of mixing applications are handled seamlessly in shorter timespan without compromising on the results.

According to the FMI report, the vacuum mixing devices market reflects a fair degree of fragmentation, wherein a large pool of regional manufacturers is competing neck to neck. Stryker Corporation and Zimmer Biomet remain two of the market goliaths, with strong product portfolios and extended regional presence.

A majority of the revenues of these two companies are generated from the US and Germany, and their focus on strategic collaborations will continue to yield significant profit benefits and ensure sustained growth. For instance, in 2021, Zimmer Biomet Holdings, Inc. – a global leader in musculoskeletal healthcare – collaborated with Apple to transform the patients’ journey for two most common type of surgeries undergone by the Americans every year – knee and hip replacement. This collaboration was aimed at popularizing the Zimmer Biomet ‘mymobility™’ app, an app that makes use of Apple Watch to facilitate constructive connections between patients and their respective surgical teams.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7515

The FMI analyst finds that though the factors conditioning success differ for market players of varying statures, but in all the cases, the market partakers will have to be adept at effective tracking of the evolving market trends and make necessary adaptations.

Portability: The New Normal Grappling End User AppealIn 2021, the devices with vertical orientation is estimated to surpass other variants and account for over ½ of the global vacuum mixing devices-derived value. Though end users will continue to invest in vertical vacuum mixing devices, the demand for rotational vacuum mixing devices will also see a considerable uptick through 2022, unveils FMI.

With ‘portable’ emerging as the new norm in the medical laboratory equipment space, manufacturers are jumping onto the ‘portability’ bandwagon by launching newer models of vacuum mixing devices that are easy-to-carry and compact in size. According to the FMI analysis, North America (29%) and Europe (26%) will continue to be the leading markets for vacuum mixing devices in 2022 and beyond, set in motion by robust healthcare infrastructure and massive investments in development of high-quality laboratory essentials.

Vacuum mixing devices worth ~ US$ 128 Mn were sold in hospitals in 2021, primarily driven by the growing number of inpatient and outpatient procedures. Manufacturers, to draw upon this increase in demand, are focusing on effective marketing of their products to hospitals by using ‘easy-to-use’ and ‘compatibility with varying viscosities’ as two of their key marketing touchpoints. However, various regulations put in place for manufacturing of vacuum mixing devices will continue to impede its penetration by increasing the ‘time-to-market’ factor.

This study sheds light on the untapped opportunities in the vacuum mixing devices market and finds the market would grow at a value CAGR of ~2.4% during the forecast period.

Key Market Segments Covered in Vacuum Mixing Devices Industry ResearchBy Product:

Vertical Vacuum-Mixing Devices
Rotational Vacuum-Mixing Devices
Vertical+Twisting Vacuum-Mixing Devices

By Modality:

Bench Top Devices
Portable Devices

By End User:

Ambulatory Surgical Centers
Hospitals
Specialty Clinics

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-7515

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Radiation Toxicity Treatment Market is expected to reach US$ 5.58 Billion by 2029

[194 Pages Report] The rise in installation of radiation therapy machines to treat a wide range of cancers further uplifts the probability of radiation toxicity in cancer patients. Future Market Insights (FMI), in its new study on the global radiation toxicity treatment market, foresees that the market will reach the value of US$ 5.5 Bn by the end of forecast period (2022 – 2029) and further experience a major upturn post 2029.

Installed base of internal radiation therapy machines has tremendously increased over the past decade. Improving reimbursement scenario and favorable government policy framework in the field of cancer care are adding to the accessibility of radiation therapy, thereby favoring the growth of radiation toxicity treatment market.

The study suggests that notable players in Asia Pacific will continue to invest heavily in the development of new radiation therapies, in line with the increasing cancer prevalence and improving rate of diagnosis in the region.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-10724

Rising incidence of radiation toxicity in healthcare and chemicals industries continues to push the demand for effective treatment. Another important factor complementing the market growth includes recent FDA approvals to multiple orphan drugs that are proven to effectively increase the survival rate in adult and paediatric patients who are suffering from radiation sickness. These application areas continue to create growth opportunities in the radiation toxicity treatment market.

Key Takeaways – Radiation Toxicity Treatment Market Study

Increasing adoption of colony stimulating factors such as Neulasta from Amgen will account for more than 75% of revenue share in the radiation toxicity treatment market through 2029 end.
Attributed to high incidences of radiation toxicity due to emission of gamma radiation from positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scanners installed at hospitals and diagnostic centers, non-ionizing radiation is also set to offer lucrative opportunity to market participants.
North America continues to lead its way in the radiation toxicity treatment market, while South Asia is foreseen to grow at a significant rate in the near future.

Who Is Winning?

Some of the key players operating in the radiation toxicity treatment market include Amgen Inc., Partner Therapeutics, Mylan N.V., and Novartis AG. Leading players of the radiation toxicity treatment market are focusing on acquiring smaller companies to enhance their product portfolio and improve regional market positioning.

For instance, Siegfried Group announced the acquisition of drug product manufacturing facility together with all related employees and contracts from Arena Pharmaceuticals GmbH in Zofingen, Switzerland. Also, in 2018, Partner Therapeutics (PTx) acquired global rights to develop, manufacture, and commercialize Leukine (sargramostim) from Sanofi.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-10724

Know More About the Report

Radiation toxicity treatment market, a new study from future market insights, opines on the evolution of the radiation toxicity treatment market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; product type (colony stimulating factors, potassium iodide, prussian blue, diethylenetriamine pentaacetic acid, and others), indication (acute radiation syndrome and chronic radiation syndrome), radiation type (ionizing radiation and non-ionizing radiation) and end user (hospitals and research & academic institutes) across seven prominent regions.

Radiation toxicity treatment Market by Category

By Product :

Colony Stimulating Factors
Potassium Iodide
Prussian Blue
Diethylenetriamine Pentaacetic Acid
Others

By Indication :

Acute Radiation Syndrome
- Bone Marrow Syndrome (Hematopoietic)
- Gastrointestinal Syndrome (GI)
- Cardiovascular (CV)
Chronic Radiation Syndrome

By Radiation Type :

Ionizing Radiation
- Alpha Radiation
- Beta Radiation
- Gamma Radiation
Non-ionizing Radiation

By End-User :

Hospitals
- Government Hospitals
- Private Hospitals
Research & Academic Institutes
- Government Research and Academic Institutes
- Private Research and Academic Institutes

By Region :

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-10724

Counterfeit Drug Detection Device Market is estimated value of around US$ 1.14 Billion as of 2022

[205 Pages Report] The Global Counterfeit Drug Detection Device market study provides critical information related to the global, regional and top players including Counterfeit Drug Detection Device market share analysis, winning strategies, recent developments, and financial planning. Besides providing information regarding the key players in the Counterfeit Drug Detection Device market, the study also recalibrates, the impact of macroeconomic and microeconomic factors that has the potential to impact the growth of the Counterfeit Drug Detection Device market.

Driven by governments’ efforts towards development of centralized and organized tracking systems, the global demand for counterfeit drug detection devices will see 1.5X expansion over the decade-old forecast period (2022 – 2029). Increasing surveillance practices of the Drug Enforcement Agency and Customs and Border Protection to conduct screening activities on medicines and health products will remain pivotal in the market build-up.

Governments also continue to conduct awareness about fake drugs, which would be among the key factors limiting supply of counterfeit drugs. This, in turn, will drive the growth of counterfeit drug detection devices market. For an instance, the European Union recently introduced falsified Medicine Directive (FMD) to address threats of counterfeit medicines impacting entire supply chain.

Key Takeaways

Although benchtop devices are most suitable for use in laboratories, development of handheld devices is offering more feasibility in the in-field testing area. Faster results and in-field applications of handheld devices offer lucrative growth opportunity.
Well-established regulation that is constantly updated for identification of counterfeit drugs along with increasing awareness for these drugs in North America are factors that make the region lucrative for growth of the counterfeit drug detection device market.
In terms of product, chemical composition detection devices account for a significant share in the counterfeit drug detection device market value. This growth is primarily attributed to the changing trend from on-package tracing to on-drug/on-product tracing methods.

Greater emphasis of regulatory bodies on development of regulations such as FMD in Europe to reduce counterfeit drug supply will be offering ample growth opportunities to market players in the near future.

To remain ‘ahead’ of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-7838

What Are the Key Imperatives of Market Winners?

Some of the key players offering counterfeit drug detection devices include Spectris, Thermo Fisher Scientific, Inc, Olympus Corporation, Metrohm AG, and Rigaku Corporation. Top four companies (Thermofisher Scientific Inc, Olympus Corporation, Spectris, and Rigaku Corporation) currently contribute nearly 60% share in the market revenues.

Some of the prominent companies are focused towards the development of innovative track and trace technology such as Trutag, while others continue to dedicate focus to geographical expansion. Product portfolio through acquisition of smaller players would be one of the key strategies adopted by market leaders.

Besides the development of on-drug tracking technologies, new methodologies such as paper-based test cards are being developed to identify counterfeit drugs at the purchase point. However, these paper-based test cards still require further testing before their deployment in the market.

Know More About What the Report Covers

The counterfeit drug detection device market, a new study from Future Market Insights, provides unparalleled insights on evolution of the drug detection devices during 2014 – 2021 and presents demand projections during 2022 – 2029 on the basis of product category (counterfeit chemical composition detection devices and counterfeit packaging & labelling detection devices), modality (portable devices, handheld devices and benchtop devices), and end user (pharmaceutical companies, drug testing laboratories, and research organizations) across seven prominent regions.

Key Market Segments Covered In Counterfeit Drug Detection Device Industry ResearchBy Product :

Counterfeit Chemical Composition Detection Devices
- Ultraviolet/Vis Devices
- Infrared & Near Infrared Spectroscopy Device
- Raman Spectrometers
- XRD & XRF Spectroscopy Devices
Counterfeit Packaging & Labelling Detection Devices
- RFID Analyzer
- Scanning & Imaging Systems
- Others

By Modality :

Portable Devices
Hand-held Devices
Bench-top Devices

By End User :

Pharmaceutical Companies
Drug Testing Laboratories
Research Organization

Any Queries About Report, Contact Us @ https://www.futuremarketinsights.com/askus/rep-gb-7838

By Region :

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Cardiac Assist Devices Market is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Billion by 2031

[195 Pages Report] Future Market Insights (FMI), a Leading Market Research and Competitive Intelligence Provider Offers Exhaustive Analysis on Key Factors Burgeoning the Sales in the Global Cardiac Assist Devices Market over the Assessment Period (2021-2031)

Future Market Insight’s (FMI’s) latest study published on the Cardiac Assist Devices market provide insights into key factors uplifting the sales over the next ten years. It provides unbiased analysis on key trends, drivers, and opportunities across key segments, the report also provides strategic analysis on the incumbents, existing players, and leading players operating in the Cardiac Assist Devices market. As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Cardiac Assist Devices market is projected to witness robust growth during the forecast year 2021-2031. The report emphasizes on providing key insights into diverse features including demand, product developments, revenue generation, and sales in the Cardiac Assist Devices market.

The study offers a detailed analysis of dynamics including driver, restraints, opportunities, and challenges, and also highlights their consequent impact on the market.

“To remain ‘ahead’ of your competitors, request for a sample”: https://www.futuremarketinsights.com/reports/sample/rep-gb-467

Advent of Telehealth and Virtual Care to Create Tailwind for the Cardiac Assist Devices Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth have gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Cardiac Assist Devices market.

Key Cardiac Assist Devices Market Takeaways and Projections

The U.S. is estimated to continue dominating the North America market, projecting fastest growth in the region through 2031.
Germany Cardiac Assist Devices market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2021 and 2031.
China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-467

Report Benefits & Key Questions Answered

Cardiac Assist Devices Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Cardiac Assist Devices market. It also studies the impact of these dynamics on the market for the previous assessment period 2016-2020 to forecast the scope of market growth over the coming forecast period 2021-2031.
Cardiac Assist Devices Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Cardiac Assist Devices market. As per the survey, Cardiac Assist Devices sales will project steady growth over the forecast period.

Cardiac Assist Devices Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Cardiac Assist Devices market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
Cardiac Assist Devices Category & Segment Level Analysis: FMI’s category & segment level analysis provides insights into key factors affecting the market growth across various segments in terms of (segment 1), (segment 2), and (segment 3). It also uncovers critical opportunities across each segment to assist key players to capitalize on the,
Cardiac Assist Devices Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Cardiac Assist Devices market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Cardiac Assist Devices market.

Some of the prominent market players are profiled by FMI

Terumo Corporation
Medtronic PLC
Abbott Laboratories
Abiomed Inc.
Teleflex Incorporated
Maquet GmbH
BerlinHeart GmbH
Others

Cardiac Assist Devices Demand Analysis by Category
By Product Type:

Ventricular Assist Devices (VAD)
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
External Ventricular Assist Devices
Intra-Aortic Balloon Pump

For critical insights, request for PDF Brochure: @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-467

By Modality Type:

Transcutaneous
Implantable

By End-User:

Hospital
Ambulatory Surgical Centers

Region

North America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Dosimetry Market SWOT Analysis, Key Indicators, Forecast 2029 : KEYPLAYERS – Honeywell, Thermo Fisher Scientific, Fortive Mirion Technologies, and Fuji Electric

Increasing adoption of dosimeters at various healthcare centers would push the global dosimetry market revenues beyond a value of US$ 4 Bn by 2029, as projected by a new Future Market Insights (FMI) report. Strict government regulations regarding radiation toxicity levels, growing awareness about the harmful effect of radiation, and rising concerns about the health of employees working in environments with radiation exposure have prompted the use of dosimetry.

Rising adoption of radiopharmaceuticals used for diagnostic purposes can increase the radiation levels in hospitals. This has, in turn, increased the risk of radiation-related diseases among healthcare professionals. There has been a rise in the adoption of wearable dosimeters by hospitals to analyse radiation levels among their staff, which has created opportunity for the growth of the dosimetry market.

“Rise in the install base of internal radiation therapy machines in the past decade has necessitated the need for active dosimeters for real-time monitoring of radiation exposure of hospital staff”, says an FMI analyst.

Key Takeaways from Dosimetry Market Study

The adoption of personal electronic dosimeters for real-time monitoring is expected to gain traction, and contribute more than 60% of revenue share during the forecast period.
Growing adoption of wearable dosimeters by hospital professionals to analyse radiation levels is expected to contribute to the significant revenue share of the segment.
Passive dosimeters dominate the market by energy, as these are relatively cheaper than active dosimeters.
In terms of end user, industrial and medical are expected to collectively gain more than 40% of market share during the forecast period.
North America is the leading market, while the dosimetry market in South Asia is expected to grow at significant rate, owing to increasing healthcare infrastructure and industrialization.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3482

Acquisition Key Strategy Followed by Leading Manufacturers

Leading manufacturers in the dosimetry market are focusing on the acquisition strategy to enhance their product portfolio and expand their regional presence. For instance, in 2017, Fortive acquired Landauer, a leading global provider of subscription-based technical and analytical services to determine occupational and environmental radiation exposure. In 2016, Mirion Technologies Inc. acquired Canberra Industries. Mirion’s acquisition of Canberra brings together two of the most respected and experienced industry players, and offers comprehensive and compelling solutions for the global customer base.

Want more insights on the dosimetry market?

A new study by Future Market Insights opines on the evolution of the dosimetry market from 2014-2018, and presents demand projections for 2019-2029, on the basis of product (personal electronic dosimeters, self-reading dosimeters, processed dosimeters), modality (wearable and non-wearable), energy (active dosimeters and passive dosimeters), and end user (industrial, medical, oil and gas, defence, homeland security, mining, environmental, others), across seven prominent regions.

DOSIMETRY MARKET TAXONOMYThe global dosimetry market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product

Personal Electronic Dosimeters
Self-reading Dosimeters
Processed Dosimeters
- Optically Stimulated Luminescence Dosimeters (OSLD)
- Thermoluminescence Dosimeters (TLD)
- Radiophotoluminescence (RPL)

Modality

Wearable
- Collar Level
- Chest Level
- Waist Level
- Wrist Level
- Finger Level
Non-wearable

Energy

Active Dosimeters
Passive Dosimeters

End User

Industrial
Medical
Oil and Gas
Defense, Homeland Security
Mining
Environmental
Others

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3482

Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Metal Polish Products Market is expected to grow at a CAGR of Approximately Over 2022-2026

Metal Polish Products Market Outlook:

Metal products are polished to create a reflective surface, inhibit the contamination of instruments, prevent the corrosion of pipes, remove oxidation as well as enhance the appearance of any item. Metal polish products are used to remove oxidation from metal objects with a motive to prevent the metal from getting corroded and increase its lifespan. Metal polish products are gaining traction in the market, owing to the high use of metals in furniture, antiques and machinery. The use of metal polish is not only limited to clean metals and restore shine, but it also helps in removing a layer of oxidation as oxidized metal has a bad finish, looks dull and stains easily. Rising consumer demand for a smoother microscopic surface, better reflection, high gloss and shine in metal products is a key contributing factor to the growth of the metal polish products market. The supply-side participants in the metal polish products market are engaged in the innovation of new products to cater to the consumer demand and thereby complement the growth of the metal polish products market.

To Get a Sample Copy of the Report visit @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8486

Technological Advancements & New Product Innovation drive the Adoption of Metal Polish Products

The global metal polish products market has been registering rapid growth, owing to the use of different metal alloys in machinery, furniture and other metal products due to their cheaper cost and high efficiency. Metal polish products are available in different forms such as foam, tablet, gel, spray and liquid, depending upon the application. The rising awareness about the availability of these products also complements the growth of the metal polish market. Metal polish products are used to safely clean, protect and shine metal surfaces without causing damage. Recently, a sudden hike in the demand for metal polish products has been observed, owing to their versatile nature, to remove tarnish, clean surface dust, prevent corrosion and surface rust and inhibit oxidation. Metal polish products find a wide range of applications in various metals such as silver, gold, aluminum, stainless steel, bronze, chrome, brass and more.

Metal Polish Products Market: Market Participants

The key market participants identified across the value chain of the metal polish products market are Tri-Peek International Limited, Rubbedin cleaning products, Canadian Tire Corporation, Limited., California Custom Products Inc., Reckitt Benckiser Group PLC, S. C. Johnson & Son, Inc., Diversified Chemical Technologies, Inc., White Diamond Detail Products, Weiman Products, LLC., Wizards Products, Turtle Wax, Inc., Halfords Limited, Menzerna polishing compounds GmbH & Co. KG and Cyclo Industries, Inc., among others.

Opportunities for Metal Polish Products Market Participants

Globally, the metal polish market has been witnessing significant growth, owing to the rise in the demand for cleaning and polishing products. The market is governed by the innovation of new products, owing to advancement in technology, as a result of which the manufacturers of metal polish products market keep adding new products to their portfolios. The supply-side participants of the metal polish products market are focussed on making their products more efficient and cost-effective. The emergence of e-commerce and the influence of TV commercials also play a major role in driving the growth of the metal polish products market during the forecast period.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: regional markets, form, end-use & sales channel.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-8486

The study is a source of reliable data on:

Metal Polish Products Market segments and sub-segments
Metal Polish Products Market trends and dynamics
Supply and demand
Metal Polish Products Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Metal Polish Products Market: Segmentation

On the basis of form, the metal polish products market has been segmented as:

Liquids
Sprays
Gels
Tablets
Foam

On the basis of end use, the metal polish products market has been segmented as:

Households
Industrial
Metal Manufacturing

On the basis of sales channel, the metal polish products market has been segmented as:

Hypermarkets
Supermarkets
Independent Retailers
Multi Brand Stores
Specialty Retail Stores
Online Sales
Company Website
3rd Party Online Sales

PRE BOOK @ https://www.futuremarketinsights.com/checkout/8486